Scheid, C., Bertsch, U., & Goldschmidt, H. (2014). Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: A subgroup analysis from the HOVON-65/GMMG-HD4 trial. Haematologica, 99(1), . https://doi.org/10.3324/haematol.2013.087585
Chicago-Zitierstil (17. Ausg.)Scheid, Christoph, Uta Bertsch, und Hartmut Goldschmidt. "Bortezomib Before and After Autologous Stem Cell Transplantation Overcomes the Negative Prognostic Impact of Renal Impairment in Newly Diagnosed Multiple Myeloma: A Subgroup Analysis from the HOVON-65/GMMG-HD4 Trial." Haematologica 99, no. 1 (2014). https://doi.org/10.3324/haematol.2013.087585.
MLA-Zitierstil (9. Ausg.)Scheid, Christoph, et al. "Bortezomib Before and After Autologous Stem Cell Transplantation Overcomes the Negative Prognostic Impact of Renal Impairment in Newly Diagnosed Multiple Myeloma: A Subgroup Analysis from the HOVON-65/GMMG-HD4 Trial." Haematologica, vol. 99, no. 1, 2014, https://doi.org/10.3324/haematol.2013.087585.